Mexico Allergy Diagnostics Market (2026-2031)
The Mexico Allergy Diagnostics Market was valued at $77.4 Million in 2026 and projected to reach to $132.1 Million by 2031, representing a compound annual growth rate of 11.3%. Mexico's allergy diagnostics market is positioned for sustained growth through 2031, driven by rising allergic disease prevalence, improved healthcare accessibility, and increasing patient awareness.
Mexico Allergy Diagnostics Market Trends and Insights
- This represents a compound annual growth rate (CAGR) of 11.3%, significantly outpacing global market growth.
- Mexico's market growth is driven by rising prevalence of allergic diseases, increasing healthcare awareness, and expanding diagnostic infrastructure across urban and emerging healthcare centers. The Mexican allergy diagnostics sector benefits from growing patient demand for accurate diagnostic testing and improved access to specialized allergy services.
- Mexico's healthcare modernization initiatives and rising disposable incomes are enabling broader adoption of advanced diagnostic technologies.
- Between 2026 and 2031, Mexico is expected to consolidate its position as a key Latin American market for allergy diagnostics, supported by demographic trends and healthcare investment..
Key Market Statistics
- CAGR (2026-2031) 11.3% CAGR
- Market Size, 2026 ~USD 77.4 Million
- Forecast, 2031 ~USD 132.1 Million
- Country Mexico
Mexico Allergy Diagnostics Market Overview
Rapid Market Expansion :
Mexico's allergy diagnostics market is growing at 11.3% CAGR, significantly outpacing the global rate of 9.6%, demonstrating strong regional momentum and investment potential.
Substantial Market Growth :
Market valuation is projected to increase from USD 77.4 million in 2026 to USD 132.1 million by 2031, representing a 70.6% increase over five years.
Rising Disease Prevalence :
Increasing prevalence of allergic diseases across Mexico's population is driving demand for advanced diagnostic solutions and early detection capabilities.
Healthcare Infrastructure Development :
Expanding diagnostic infrastructure and growing healthcare awareness among Mexican consumers are creating new opportunities for allergy testing adoption and market penetration.
Mexico Allergy Diagnostics Market Dynamics
- The market's 11.3% CAGR reflects strong demand for diagnostic solutions across urban and emerging healthcare centers.
- Healthcare providers are investing in advanced testing technologies to meet growing patient needs, while government health initiatives support diagnostic expansion.
- Mexico's young, growing population with increasing environmental allergen exposure presents significant opportunities for market players.
- Strategic partnerships with local healthcare facilities and diagnostic centers will be critical for capturing market share in this dynamic landscape..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Mexico's allergy diagnostics market will grow from $77.4M (2026) to $132.1M (2031) at an 11.3% CAGR.
- Mexico's growth rate exceeds the global average, reflecting strong regional demand and healthcare expansion.
- Rising allergic disease prevalence and healthcare modernization are primary growth catalysts in Mexico.
- Mexico represents a strategic opportunity for diagnostic providers targeting Latin American markets.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
Mexico Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Equipment Manufacturers : Need Mexico-specific market data to assess demand for allergy testing equipment, identify distribution channels, and develop localized product strategies for this high-growth market.
- Healthcare Providers & Hospitals : Require market insights to justify investments in allergy diagnostic capabilities, understand patient demand trends, and benchmark service offerings against regional competitors in Mexico.
- In Vitro Diagnostics Companies : Seek detailed Mexico market analysis to evaluate commercial opportunities, competitive positioning, and regulatory requirements for launching allergy diagnostic tests and services.
- Healthcare Investors & PE Firms : Need comprehensive market sizing and growth projections for Mexico to evaluate investment opportunities in diagnostic companies, healthcare facilities, and related healthcare infrastructure.
- Market Research & Consulting Firms : Require granular Mexico market data and forecasts to support client advisory services, competitive analysis, and strategic recommendations in the allergy diagnostics sector.
Key Companies in the Mexico Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- Market Size & Growth Data : Access precise valuation figures for Mexico's allergy diagnostics market with detailed CAGR analysis, enabling accurate financial forecasting and investment decision-making for the 2026-2031 period.
- Competitive Landscape Intelligence : Understand Mexico-specific market dynamics, key players, and competitive positioning to identify partnership opportunities and market entry strategies tailored to local conditions.
- Growth Driver Analysis : Gain insights into Mexico's unique market drivers including disease prevalence trends, healthcare infrastructure development, and consumer awareness patterns influencing diagnostic adoption.
- Regional Market Segmentation : Obtain detailed breakdowns of Mexico's market by diagnostic type, end-user segments, and geographic regions to optimize product positioning and resource allocation strategies.
- Strategic Planning Support : Leverage comprehensive Mexico market forecasts and trend analysis to develop targeted go-to-market strategies, pricing models, and expansion plans for healthcare organizations and diagnostic providers.
Frequently asked questions
What is the current size of Mexico's allergy diagnostics market?
Mexico's allergy diagnostics market is valued at USD 77.4 million in 2026.
What is the projected market size for Mexico by 2031?
Mexico's allergy diagnostics market is forecast to reach USD 132.1 million by 2031.
What is Mexico's allergy diagnostics market CAGR?
Mexico's allergy diagnostics market is growing at a compound annual growth rate of 11.3% from 2026 to 2031.
How does Mexico's growth compare to global trends?
Mexico's 11.3% CAGR exceeds the global allergy diagnostics market CAGR of 9.6%, indicating stronger regional growth momentum.
What factors are driving growth in Mexico's allergy diagnostics market?
Key drivers include rising allergic disease prevalence, healthcare modernization, increased diagnostic awareness, and expanding access to specialized allergy services across Mexico.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report